AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
258.24B
Market cap258.24B
Price-Earnings ratio
31.03
Price-Earnings ratio31.03
Dividend yield
1.84%
Dividend yield1.84%
Average volume
4.09M
Average volume4.09M
High today
$83.52
High today$83.52
Low today
$82.65
Low today$82.65
Open price
$83.47
Open price$83.47
Volume
2.37M
Volume2.37M
52 Week high
$86.57
52 Week high$86.57
52 Week low
$61.24
52 Week low$61.24

AZN News

TipRanks 21h
AstraZeneca’s New Obesity Drug Study: What Investors Need to Know

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 2d
AstraZeneca’s AZD4604: Promising Developments in Asthma Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 3d
Novavax Enters Lease Agreement with AstraZeneca

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

78%

of 32 ratings
Buy
78.1%
Hold
18.8%
Sell
3.1%

More AZN News

TipRanks 3d
AstraZeneca, Amgen’s Tezspire approved in EU as add-on therapy

AstraZeneca (AZN) and Amgen’s (AMGN) Tezspire has been approved in the European Union, EU, as an add-on therapy with intranasal corticosteroids for the treatmen...

Nasdaq 3d
AstraZeneca And Amgen's Tezspire Approved In EU For Severe Nasal Polyps

(RTTNews) - AstraZeneca (AZN) and Amgen (AMGN) announced that Tezspire (tezepelumab) has received European Union approval as an add-on therapy with intranasal c...

AstraZeneca And Amgen's Tezspire Approved In EU For Severe Nasal Polyps
MarketWatch 5d
AstraZeneca hails major breakthroughs with breast-cancer drugs

An AstraZeneca executive says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of c...

AstraZeneca hails major breakthroughs with breast-cancer drugs
TipRanks 5d
AstraZeneca’s Tezspire Gains FDA Approval for New Indication

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 6d
AstraZeneca, Daiichi announce results from DESTINY-Breast11 Phase III trial

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) announce positive results from the DESTINY-Breast11 Phase III trial showed Enhertu followed by paclitaxel, trastuzu...

TipRanks 6d
Gilead, AstraZeneca, and Roche Data Signal New Growth in Cancer Drug Market

Three large drug companies shared new study results this week that point to more progress in breast cancer treatment. The news came during the European Society...

Investor's Business Daily 7d
AstraZeneca, In A Buy Zone, Makes A Big Breast Cancer Splash

AstraZeneca's (AZN) Enhertu could help some breast cancer patients avoid surgery, according to a study unveiled Saturday at the European Society of Medical Onco...

AstraZeneca, In A Buy Zone, Makes A Big Breast Cancer Splash
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.